141 Participants Needed

CBT and Light Therapy for Seasonal Affective Disorder

KJ
Overseen ByKelly J Rohan, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Vermont
Must be taking: Antidepressants
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Major depression is a highly prevalent, chronic, and debilitating mental health problem with significant social cost that poses a tremendous economic burden. Winter seasonal affective disorder (SAD) is a subtype of recurrent major depression that affects 5% of the population (14.5 million Americans), involving substantial depressive symptoms for about 5 months of each year during most years, beginning in young adulthood.

Who Is on the Research Team?

KJ

Kelly J Rohan, Ph.D.

Principal Investigator

University of Vermont

Are You a Good Fit for This Trial?

This trial is for adults with major depression that follows a seasonal pattern, known as Winter SAD. Participants should have consistent symptoms each year and not be on changing doses of antidepressants. It's not for those who've had light therapy or CBT for SAD before, have other urgent mental health issues, are at high risk of suicide, will be away during the study period, or have eye conditions affected by bright light.

Inclusion Criteria

I have been diagnosed with seasonal depression that comes back.
I have been on a stable dose of antidepressants for over 4 weeks with no changes planned.
Meet Structured Interview Guide for the Hamilton Rating Scale for Depression-Seasonal Affective Disorder Version (SIGH-SAD) criteria for a current SAD episode
See 1 more

Exclusion Criteria

Presence of a comorbid Axis I disorder that requires immediate treatment (i.e., bipolar disorder, psychotic disorders, substance use disorder)
I have undergone light therapy or cognitive behavioral therapy for seasonal affective disorder.
Acute and serious suicidal intent
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either CBT-SAD or Light Therapy. CBT-SAD involves 12 group sessions over 8 weeks, while Light Therapy involves daily sessions for 6 weeks.

6-8 weeks
12 visits (in-person) for CBT-SAD; daily home sessions for Light Therapy

Follow-up

Participants are monitored for depression recurrence and biomarker assessments in Winter 2 and Winter 3.

2 years
Follow-up visits in Winter 2 and Winter 3

Switch Treatment (if needed)

Participants experiencing depression recurrence are switched to the alternate treatment.

As needed

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive-Behavioral Therapy (CBT-SAD)
  • Light Therapy
Trial Overview The study tests Cognitive-Behavioral Therapy (CBT-SAD) against Light Therapy to see which is more effective in treating Seasonal Affective Disorder (SAD). The goal is to determine the best long-term treatment approach to reduce depressive episodes during winter months.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive-Behavioral Therapy (CBT-SAD)Experimental Treatment1 Intervention
Group II: Light TherapyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Vermont

Lead Sponsor

Trials
283
Recruited
3,747,000+

University of Maryland, College Park

Collaborator

Trials
163
Recruited
46,800+

University of Maryland, Baltimore

Collaborator

Trials
729
Recruited
540,000+

University of Pittsburgh

Collaborator

Trials
1,820
Recruited
16,360,000+

University of Maryland School of Medicine

Collaborator

Trials
5
Recruited
790+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security